Stuttgart - Delayed Quote EUR
Innovent Biologics, Inc. (6IB.SG)
5.80
+0.25
+(4.50%)
At close: May 16 at 8:02:19 AM GMT+2
Loading Chart for 6IB.SG
- Previous Close
5.55 - Open
5.80 - Bid 5.75 x --
- Ask 5.95 x --
- Day's Range
5.80 - 5.80 - 52 Week Range
3.64 - 6.25 - Volume
0 - Avg. Volume
528 - Market Cap (intraday)
7.42B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 6IB.SG
View MorePerformance Overview: 6IB.SG
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
6IB.SG
33.03%
HANG SENG INDEX (^HSI)
16.38%
1-Year Return
6IB.SG
25.00%
HANG SENG INDEX (^HSI)
20.48%
3-Year Return
6IB.SG
161.26%
HANG SENG INDEX (^HSI)
17.02%
5-Year Return
6IB.SG
13.73%
HANG SENG INDEX (^HSI)
1.90%
Compare To: 6IB.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6IB.SG
View MoreValuation Measures
As of 5/16/2025
Market Cap
9.56B
Enterprise Value
8.94B
Trailing P/E
--
Forward P/E
175.44
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.08
Price/Book (mrq)
5.84
Enterprise Value/Revenue
7.65
Enterprise Value/EBITDA
176.35
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: 6IB.SG
View MoreCompany Insights: 6IB.SG
Research Reports: 6IB.SG
View MorePeople Also Watch
6IB.F Innovent Biologics, Inc.
5.60
0.00%
2L9.F Blueprint Medicines Corporation
88.04
+1.87%
4DN.MU Denali Therapeutics Inc.
12.52
0.00%
A71.F Ascendis Pharma A/S
139.00
0.00%
8SJ.F Shanghai Junshi Biosciences Co., Ltd.
1.6400
+2.50%
49B.SG BeiGene, Ltd.
15.61
+2.90%
UP0.F Ultragenyx Pharmaceutical Inc.
30.80
+0.65%
9LB.F Legend Biotech Corporation
24.80
+0.81%
4DN.F Denali Therapeutics Inc.
12.54
+1.42%
49BA.F BeiGene, Ltd.
204.00
+3.55%
HDP1.F Arrowhead Pharmaceuticals, Inc.
13.59
+3.23%
4RY.F Akeso, Inc.
9.40
+0.53%
DR6.F ACADIA Pharmaceuticals Inc.
21.58
+42.54%
AM6.F Amicus Therapeutics, Inc.
5.20
0.00%
RV7.F Halozyme Therapeutics, Inc.
43.38
+2.19%
G51.F Genscript Biotech Corporation
1.1445
+0.62%